Aldeyra Therapeutics develops treatments for aldehyde toxicity-related diseases including Sjögren-Larsson Syndrome (SLS) and noninfectious anterior uveitis.

Pharmaceutical

Aldeyra Therapeutics

Aldeyra Therapeutics' headquarters in Lexington, MA, United States

Todd C. Brady

Charles Montgomery

David J. Clark

David Noskowitz

Christopher Pearson

Richard H. Douglas

Martin J. Joyce

Neal Walker

Gary Phillips

Jesse I. Treu

Ben Bronstein

The Leadership Team at Aldeyra Therapeutics is responsible for guiding the company's strategic direction and overseeing the development and commercialization of innovative treatments for aldehyde toxicity-related diseases. This multidisciplinary team, comprising executives from commercial development, clinical and regulatory affairs, and technical operations, collaborates to ensure effective execution of the company's mission, while aligning research initiatives with market needs and regulatory requirements.

Leadership Team

The Clinical and Commercial Development team at Aldeyra Therapeutics is responsible for advancing clinical trials, developing market access strategies, and translating scientific research into viable treatment options for aldehyde toxicity-related diseases such as Sjögren-Larsson Syndrome and noninfectious anterior uveitis. This team ensures that innovative therapies reach patients effectively by coordinating between clinical research, strategy development, and market implementation.

Clinical and Commercial Development

The Quality and Regulatory team at Aldeyra Therapeutics ensures compliance with industry regulations and maintains high standards for product quality. They manage regulatory submissions, oversee quality control processes, and ensure that all therapeutic products meet strict safety and efficacy guidelines.

Quality and Regulatory

The Finance team at Aldeyra Therapeutics oversees financial planning, reporting, and management to ensure the company's financial health. They handle budgeting, auditing, and regulatory compliance, playing a critical role in supporting the development of treatments for aldehyde toxicity-related diseases.

Aldeyra Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Clinical and Commercial Development

Quality and Regulatory

Finance

Offices

Aldeyra Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Clinical and Commercial Development

Quality and Regulatory

Finance

Offices

Related companies